KTZ launched Myanmar’s first Effervescent tablets, marking the brand’s entry into the market and quickly becoming the market leader. That same year, KTZ introduced Paracetamol Suppository, successfully expanding its innovative product lineup.
1997
Bringing innovation to Digestive health, KTZ launched the first Saccharomyces boulardii probiotic in Myanmar from France and rose to become leading brand in the Diarrhea treatment category.
1999
Pioneering innovation in Iron therapy, an advanced Drinkable Ampoule-Form Iron Supplement was launched.
2001
KTZ introduced its Lactulose product, Avolac,in Myanmar market. With superior quality and excellence treatment efficacy, Avolac became a Trusted Lactulose product among consumers after its launch.
2005
KTZ launched its dedicated Ophthalmic Product Line offering a variety of medicines for Opthalmic healthcare sector.
2014
Expanded the company’s portfolio with a new Orthopedic Product Line.
2017
Established a new FMCG Distribution Sector.
2022
Achieved ISO 9001:2015 (QMS) certification.
2024
Achieved GSDP (Good Storage & Distribution Practice) certification.
2024
KTZ celebrated its 30-year anniversary in 2024.
History Timeline Of
K.T.Z Company Limited
1994
Est. 1994.
1994
KTZ launched Myanmar’s first Effervescent tablets, marking the brand’s entry into the market and quickly becoming the market leader. That same year, KTZ introduced Paracetamol Suppository, successfully expanding its innovative product lineup.
1997
Bringing innovation to Digestive health, KTZ launched the first Saccharomyces boulardii probiotic in Myanmar from France and rose to become leading brand in the Diarrhea treatment category.
1999
Pioneering innovation in Iron therapy, an advanced Drinkable Ampoule-Form Iron Supplement was launched.
2001
KTZ introduced its Lactulose product, Avolac,in Myanmar market. With superior quality and excellence treatment efficacy, Avolac became a Trusted Lactulose product among consumers after its launch.
2005
KTZ launched its dedicated Ophthalmic Product Line offering a variety of medicines for Opthalmic healthcare sector.
2014
Expanded the company’s portfolio with a new Orthopedic Product Line.
2017
Established a new FMCG Distribution Sector.
2022
Achieved ISO 9001:2015 (QMS) certification.
2024
Achieved GSDP (Good Storage & Distribution Practice) certification.